Project Leo: Trauma-Informed Yoga for Preschool Children and Parents
26. august 2026 oppdatert av: Shahar Almog, Florida Atlantic University
The goal of this pilot clinical trial is to examine feasibility, acceptability, and direction of effect of a dyadic (child and parent) trauma-informed yoga intervention on stress symptoms and sleep in young children (age 3-6) after war. The main questions it aims to answer are:
- Is the intervention feasible and liked by the participants?
- Does the child-parent yoga intervention reduce the child's stress symptoms and improve their sleep?
- Does the child-parent yoga intervention improve the child-parent relationship?
Participants (child-parent dyads) will:
- Children and parents will participate together in 8 weekly group yoga sessions.
- Children and parents will engage together in a short daily at-home practice before bedtime.
- Parents will complete online surveys before and after the 8-week program, and at one-month follow-up.
- Parents will complete a daily practice-sleep log.
Studieoversikt
Status
Har ikke rekruttert ennå
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Antatt)
66
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Shahar Almog, PhD
- Telefonnummer: +1 (561) 2973461
- E-post: salmog@fau.edu
Studer Kontakt Backup
- Navn: Noga Tsur, PhD
- E-post: nogatsur@tauex.tau.ac.il
Studiesteder
-
-
Florida
-
Boca Raton, Florida, Forente stater, 33431
- Florida Atlantic University
-
-
-
-
-
Tel Aviv, Israel
- Tel Aviv University
-
Ta kontakt med:
- Noga Tsur, PhD
- Telefonnummer: 0000000000
- E-post: nogatsur@tauex.tau.ac.il
-
Hovedetterforsker:
- Noga Tsur, PhD
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
Children: Age 3-6. Per the parent's report, the child exhibits at least one stress-related symptom.
Parents: Preferably, the same parent can attend all group sessions. Having internet access at home to complete online surveys.
Exclusion Criteria:
Children: Any physical disability that prevents participating safely in yoga sessions.
Parents: Self-reported pregnancy. Any physical disability that prevents participating safely in gentle yoga sessions.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Intervention
Dyadic (Child-Parent) Yoga
|
Participants will attend 8 weekly group sessions of dyadic (child and parent) yoga and engage in at-home practice at bedtime.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Child's Stress Symptoms
Tidsramme: 8 weeks
|
Presence and severity of stress symptoms will be assessed (parent-reported) using the Young Child PTSD Checklist (YCPC).
The 30-item scale yields a sum score ranging from 0 to 120, with higher scores indicating more severe stress symptoms.
|
8 weeks
|
|
Child's Sleep Quality
Tidsramme: 8 weeks
|
The child's sleep quality will be assessed (parent-reported) using the Children's Sleep Habits Questionnaire Abbreviated (CSHQ).
The 22-item scale yields a sum score ranging from 0 to 88, with higher scores indicating more severe sleep problems.
|
8 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Child-Parent Relationship: Closeness
Tidsramme: 8 weeks
|
The quality of the child-parent relationship will be assessed (parent-reported) using the Child-Parent Relationship Scale - Short Form (CPRS-SF), specifically the Closeness subscale.
The 7-item subscale yields a sum score of 7 to 35, with higher scores indicating greater closeness.
Higher closeness scores reflect better relationship between the child and the parent.
|
8 weeks
|
|
Child-Parent Relationship: Conflict
Tidsramme: 8 weeks
|
The quality of the child-parent relationship will be assessed (parent-reported) using the Child-Parent Relationship Scale - Short Form (CPRS-SF), specifically the Conflict subscale.
The 8-item subscale yields a sum score of 8 to 40, with higher scores indicating greater conflict.
Lower conflict scores reflect better relationship between the child and the parent.
|
8 weeks
|
|
Parent's Stress Symptoms
Tidsramme: 8 weeks
|
Presence and severity of post-traumatic stress symptoms will be assessed (self-reported) using the PCL-5 scale.
The 20-item scale yields a sum score ranging from 0 to 80, with higher scores indicating more severe post-traumatic stress symptoms.
|
8 weeks
|
|
Parent's Sleep Quality
Tidsramme: 8 weeks
|
The parent's sleep quality will be assessed (self-reported) using the Sleep Disturbance PROMIS SF 8b.
The 8-item scale yields a sum score ranging from 8 to 40, with higher scores indicating more severe sleep problems.
|
8 weeks
|
|
Parental Self-Efficacy
Tidsramme: 8 weeks
|
The parent's self-confidence in their ability to handle their child's behavior problems will be assessed (self-reported) by the Brief Parental Self-Efficacy Scale.
The 5-item scale yields a sum score ranging from 5 to 20, with higher scores indicating greater self-confidence.
|
8 weeks
|
|
Child's Pain Severity
Tidsramme: 8 weeks
|
If the child experiences pain, pain severity will be assessed (parent-reported) using one item from the Brief Pain Inventory (BPI).
Pain severity will be rated on a scale from 0 to 10, with higher rating indicating more severe pain.
|
8 weeks
|
|
Child's Pain Interference
Tidsramme: 8 weeks
|
If the child experiences pain, pain interference with routine activities will be assessed (parent-reported) using one item from the Brief Pain Inventory (BPI).
The level of how much the pain interferes with routine activities will be rated on a scale from 0 to 10, with higher ratings indicating greater interference.
|
8 weeks
|
|
Parent's Pain Severity
Tidsramme: 8 weeks
|
If the parent experiences pain, pain severity will be assessed (self-reported) using one item from the Brief Pain Inventory (BPI).
Pain severity will be rated on a scale from 0 to 10, with higher rating indicating more severe pain.
|
8 weeks
|
|
Parent's Pain Interference
Tidsramme: 8 weeks
|
If the parent experiences pain, pain interference will be assessed (self-reported) using two items from the Brief Pain Inventory (BPI).
The level of how much the pain interferes with (a) enjoyment in life and with (b) routine activities will be rated on a scale from 0 to 10, with higher ratings indicating greater interference.
|
8 weeks
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility: Recruitment
Tidsramme: Recruitment period, from initiation until the start day of the intervention
|
Recruitment will be calculated as the proportion of enrolled participants to interested individuals during the recruitment period.
|
Recruitment period, from initiation until the start day of the intervention
|
|
Feasibility: Intervention Retention
Tidsramme: 8 weeks
|
Retention will be calculated as the proportion of participants who completed the intervention to participants who gave their consent to participate.
|
8 weeks
|
|
Feasibility: Intervention Adherence
Tidsramme: 8 weeks
|
Percentage of participants completing at least 75% of the group sessions AND at least 4 at-home practices per week.
Group session attendance will be monitored by the research team.
At-home practice will be self-reported via a daily practice log.
|
8 weeks
|
|
Acceptability: Liking
Tidsramme: 8 weeks
|
Parents will be asked if they liked the intervention on a scale of 0 to 10, with higher ratings indicating greater liking and better acceptability of the intervention among parents.
|
8 weeks
|
|
Acceptability: Recommending
Tidsramme: 8 weeks
|
Parents will be asked about the likelihood that they would recommend the program to others, rated from 0 to 100%, with higher ratings indicating a greater likelihood of recommending the intervention and better acceptability of the intervention among parents.
|
8 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Shahar Almog, PhD, Florida Atlantic University
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
5. oktober 2026
Primær fullføring (Antatt)
10. februar 2027
Studiet fullført (Antatt)
1. mars 2027
Datoer for studieregistrering
Først innsendt
19. august 2026
Først innsendt som oppfylte QC-kriteriene
26. august 2026
Først lagt ut (Faktiske)
27. august 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
27. august 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
26. august 2026
Sist bekreftet
1. august 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- IRB2602072
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .